Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-722P (RNA, U6 small nuclear 722, pseudogene) is classified as a pseudogene of the U6 small nuclear RNA family[5]. The U6 snRNA is a small, highly conserved non-coding RNA critical for pre-mRNA splicing as part of the spliceosome, where it helps coordinate splicing chemistry and structural interactions[1]. However, RNU6-722P itself is not a functional gene and does not produce a functional RNA product. It is one of many pseudogenized copies and is not expressed with known physiological or pathophysiological relevance[5][3]. There is no evidence for a direct biological function, drug interaction, or disease association for RNU6-722P. Pseudogenes like RNU6-722P generally arise via retrotransposition or duplication events and are typically unexpressed or non-functional[3][2]. While some pseudogenes can acquire regulatory functions or be transcribed under rare circumstances, no such roles have been documented for RNU6-722P. RNU6-722P should not be mistaken for the functional U6 snRNA, which is essential for the major spliceosomal complex; the pseudogene lacks the sequence elements needed for proper expression, stability, or function[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 722, pseudogene (RNU6-722P).